Depression in context: Important considerations for youth with type 1 vs type 2 diabetes.


Journal

Pediatric diabetes
ISSN: 1399-5448
Titre abrégé: Pediatr Diabetes
Pays: Denmark
ID NLM: 100939345

Informations de publication

Date de publication:
02 2020
Historique:
received: 19 06 2019
revised: 01 10 2019
accepted: 13 10 2019
pubmed: 24 10 2019
medline: 17 2 2021
entrez: 24 10 2019
Statut: ppublish

Résumé

Youth with diabetes are at increased risk for depression. However, severity and correlates of depressive symptoms may differ by diabetes type. Associations of depressive symptoms with global health, diabetes duration, and gender were compared between youth with type 1 and type 2 diabetes. A sample of 149 youth ages 12 to 21 diagnosed with either type 1 (n = 122) or type 2 (n = 27) diabetes were screened during routine clinic appointments. Regression models were constructed to examine differences by diabetes type. Adolescents with type 2 diabetes had significantly higher depressive symptom scores (4.89 vs 2.99, P = .025) than those with type 1 diabetes. A significant interaction between global health and diabetes type on depressive symptoms revealed inverse associations between global health and depressive symptoms that was stronger among youth with type 2 diabetes (β = -.98, P < .001) than type 1 (β = -.48, P < .001). Further probing revealed that among youth with better global health, adolescents with type 1 had more depressive symptoms than those with type 2 diabetes (β = .33, P = .035). Diabetes duration and depressive symptoms were positively associated among individuals with type 2 (β = .86, P = .043), but not type 1 diabetes. No gender differences were detected. These findings suggest that correlates of depressive symptoms in youth with diabetes differ by diabetes type. Global health appears to be an important correlate among youth with both types, whereas diabetes duration was only a significant factor among those with type 2 diabetes. The current findings can inform future psychosocial intervention efforts within both these populations.

Sections du résumé

BACKGROUND
Youth with diabetes are at increased risk for depression. However, severity and correlates of depressive symptoms may differ by diabetes type.
OBJECTIVE
Associations of depressive symptoms with global health, diabetes duration, and gender were compared between youth with type 1 and type 2 diabetes.
METHODS
A sample of 149 youth ages 12 to 21 diagnosed with either type 1 (n = 122) or type 2 (n = 27) diabetes were screened during routine clinic appointments. Regression models were constructed to examine differences by diabetes type.
RESULTS
Adolescents with type 2 diabetes had significantly higher depressive symptom scores (4.89 vs 2.99, P = .025) than those with type 1 diabetes. A significant interaction between global health and diabetes type on depressive symptoms revealed inverse associations between global health and depressive symptoms that was stronger among youth with type 2 diabetes (β = -.98, P < .001) than type 1 (β = -.48, P < .001). Further probing revealed that among youth with better global health, adolescents with type 1 had more depressive symptoms than those with type 2 diabetes (β = .33, P = .035). Diabetes duration and depressive symptoms were positively associated among individuals with type 2 (β = .86, P = .043), but not type 1 diabetes. No gender differences were detected.
CONCLUSION
These findings suggest that correlates of depressive symptoms in youth with diabetes differ by diabetes type. Global health appears to be an important correlate among youth with both types, whereas diabetes duration was only a significant factor among those with type 2 diabetes. The current findings can inform future psychosocial intervention efforts within both these populations.

Identifiants

pubmed: 31644828
doi: 10.1111/pedi.12939
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

135-142

Informations de copyright

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Johnson B, Eiser C, Young V, Brierley S, Heller S. Prevalence of depression among young people with type 1 diabetes: a systematic review. Diabet Med J Br Diabet Assoc. 2013;30(2):199-208. https://doi.org/10.1111/j.1464-5491.2012.03721.x.
Lawrence JM, Standiford DA, Loots B, et al. Prevalence and correlates of depressed mood among youth with diabetes: the SEARCH for diabetes in youth study. Pediatrics. 2006;117(4):1348-1358. https://doi.org/10.1542/peds.2005-1398.
Silverstein J, Cheng P, Ruedy KJ, et al. Depressive symptoms in youth with type 1 or type 2 diabetes: results of the pediatric diabetes consortium screening assessment of depression in diabetes study. Diabetes Care. 2015;38(12):2341-2343. https://doi.org/10.2337/dc15-0982.
Katon WJ, Korff MV, Ciechanowski P, et al. Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care. 2004;27(4):914-920. https://doi.org/10.2337/diacare.27.4.914.
Semenkovich K, Brown ME, Svrakic DM, Lustman PJ. Depression in type 2 diabetes mellitus: prevalence, impact, and treatment. Drugs. 2015;75(6):577-587. https://doi.org/10.1007/s40265-015-0347-4.
Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care. 2002;25(3):464-470. https://doi.org/10.2337/diacare.25.3.464.
Nichols L, Barton PL, Glazner J, McCollum M. Diabetes, minor depression and health care utilization and expenditures: a retrospective database study. Cost Eff Resour Alloc. 2007;5(1):4. https://doi.org/10.1186/1478-7547-5-4.
Stewart SM, Rao U, Emslie GJ, Klein D, White PC. Depressive symptoms predict hospitalization for adolescents with type 1 diabetes mellitus. Pediatrics. 2005;115(5):1315-1319. https://doi.org/10.1542/peds.2004-1717.
Barnacle M, Strand MA, Werremeyer A, Maack B, Petry N. Depression screening in diabetes care to improve outcomes: are we meeting the challenge? Diabetes Educ. 2016;42(5):646-651. https://doi.org/10.1177/0145721716662917.
Corathers SD, Kichler J, N-HY J, et al. Improving depression screening for adolescents with type 1 diabetes. Pediatrics. 2013;132(5):e1395-e1402. https://doi.org/10.1542/peds.2013-0681.
Young-Hyman D, de Groot M, Hill-Briggs F, Gonzalez JS, Hood K, Peyrot M. Psychosocial care for people with diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2016;39(12):2126-2140. https://doi.org/10.2337/dc16-2053.
Nadeau KJ, Anderson BJ, Berg EG, et al. Youth-onset type 2 diabetes consensus report: current status, challenges, and priorities. Diabetes Care. 2016;39(9):1635-1642. https://doi.org/10.2337/dc16-1066.
TODAY Study Group, Zeitler P, Hirst K, et al. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med. 2012;366(24):2247-2256. https://doi.org/10.1056/NEJMoa1109333.
La Greca AM, Swales T, Klemp S, Madigan S, Skyler J. Adolescents with diabetes: gender differences in psychosocial functioning and glycemic control. Child Health Care. 1995;24(1):61-78. https://doi.org/10.1207/s15326888chc2401_6.
Vila G, Robert JJ, Nollet-Clemencon C, et al. Eating and emotional disorders in adolescent obese girls with insulin-dependent diabetes mellitus. Eur Child Adolesc Psychiatry. 1995;4(4):270-279.
Nolen-Hoeksema S, Girgus JS. The emergence of gender differences in depression during adolescence. Psychol Bull. 1994;115(3):424-443.
Skinner TC, Carey ME, Cradock S, et al. Depressive symptoms in the first year from diagnosis of type 2 diabetes: results from the DESMOND trial. Diabet Med. 2010;27(8):965-967. https://doi.org/10.1111/j.1464-5491.2010.03028.x.
Whittemore R, Kanner S, Singleton S, Hamrin V, Chiu J, Grey M. Correlates of depressive symptoms in adolescents with type 1 diabetes. Pediatr Diabetes. 2002;3(3):135-143. https://doi.org/10.1034/j.1399-5448.2002.30303.x.
Engum A, Mykletun A, Midthjell K, Holen A, Dahl AA. Depression and diabetes: a large population-based study of sociodemographic, lifestyle, and clinical factors associated with depression in type 1 and type 2 diabetes. Diabetes Care. 2005;28(8):1904-1909. https://doi.org/10.2337/diacare.28.8.1904.
Boehme S, Geiser C, Renneberg B. Functional and self-rated health mediate the association between physical indicators of diabetes and depressive symptoms. BMC Fam Pract. 2014;15:157. https://doi.org/10.1186/1471-2296-15-157.
Zullig KJ, Valois RF, Drane JW. Adolescent distinctions between quality of life and self-rated health in quality of life research. Health Qual Life Outcomes. 2005;3(1):64. https://doi.org/10.1186/1477-7525-3-64.
de Groot M, Jacobson AM, Samson JA, Welch G. Glycemic control and major depression in patients with type 1 and type 2 diabetes mellitus. J Psychosom Res. 1999;46(5):425-435. https://doi.org/10.1016/S0022-3999(99)00014-8.
Ciechanowski PS, Katon WJ, Russo JE, Hirsch IB. The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry. 2003;25(4):246-252. https://doi.org/10.1016/S0163-8343(03)00055-0.
Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care. 2000;23(7):934-942.
Iturralde E, Adams RN, Barley RC, et al. Implementation of depression screening and Global Health assessment in pediatric subspecialty clinics. J Adolesc Health. 2017;61(5):591-598. https://doi.org/10.1016/j.jadohealth.2017.05.030.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381. https://doi.org/10.1016/j.jbi.2008.08.010.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613.
Richardson LP, Russo JE, Lozano P, McCauley E, Katon WJ. The effect of comorbid anxiety and depressive disorders on health care utilization and costs among adolescents with asthma. Gen Hosp Psychiatry. 2008;30(5):398-406. https://doi.org/10.1016/j.genhosppsych.2008.06.004.
Glick BA, Hong KMC, Obrynba K, Kamboj MK, Hoffman RP. Identifying depressive symptoms among diabetes type and the impact on hemoglobin A1c. J Pediatr Endocrinol Metab JPEM. 2018;31(1):39-44. https://doi.org/10.1515/jpem-2017-0241.
Richardson LP, McCauley E, Grossman DC, et al. Evaluation of the patient health questionnaire-9 item for detecting major depression among adolescents. Pediatrics. 2010;126(6):1117-1123. https://doi.org/10.1542/peds.2010-0852.
Forrest CB, Bevans KB, Pratiwadi R, et al. Development of the PROMIS® pediatric global health (PGH-7) measure. Qual Life Res. 2014;23(4):1221-1231. https://doi.org/10.1007/s11136-013-0581-8.
Forrest CB, Tucker CA, Ravens-Sieberer U, et al. Concurrent validity of the PROMIS® pediatric global health measure. Qual Life Res. 2016;25(3):739-751. https://doi.org/10.1007/s11136-015-1111-7.
American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care. 2013;36(Suppl 1):S11-S66. https://doi.org/10.2337/dc13-S011.
Cohen P, Aiken LS, West SG. Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences. New York, NY: Psychology Press; 2014.
Corp IBM. IBM SPSS Stastisticsfor Macintosh, Version 25.0. IBM Corp: Armonk, NY; 2017.
Barry SA, Harlan DM, Johnson NL, MacGregor KL. State of behavioral health integration in U.S. diabetes care: how close are we to ADA recommendations? Diabetes Care. 2018;41(7):e115-e116. https://doi.org/10.2337/dc18-0642.
Constantino MI, Molyneaux L, Limacher-Gisler F, et al. Long-term complications and mortality in young-onset diabetes: type 2 diabetes is more hazardous and lethal than type 1 diabetes. Diabetes Care. 2013;36(12):3863-3869. https://doi.org/10.2337/dc12-2455.
Jaser SS, Holl MG, Jefferson V, Grey M. Correlates of depressive symptoms in urban youth at risk for type 2 diabetes mellitus. J Sch Health. 2009;79(6):286-292. https://doi.org/10.1111/j.1746-1561.2009.00411.x.
Hood KK, Beavers DP, Yi-Frazier J, et al. Psychosocial burden and glycemic control during the first 6 years of diabetes: results from the SEARCH for diabetes in youth study. J Adolesc Health. 2014;55(4):498-504. https://doi.org/10.1016/j.jadohealth.2014.03.011.
Liu NF, Brown AS, Folias AE, et al. Stigma in people with type 1 or type 2 diabetes. Clin Diabetes. 2017;35(1):27-34. https://doi.org/10.2337/cd16-0020.
American Diabetes Association. Type 2 diabetes in children and adolescents. Pediatrics. 2000;105(3):671-680. https://doi.org/10.1542/peds.105.3.671.
Rautio N, Jokelainen J, Oksa H, et al. Family history of diabetes and effectiveness of lifestyle counselling on the cardio-metabolic risk profile in individuals at high risk of type 2 diabetes: 1-year follow-up of the FIN-D2D project. Diabet Med J Br Diabet Assoc. 2012;29(2):207-211. https://doi.org/10.1111/j.1464-5491.2011.03388.x.

Auteurs

Jessie J Wong (JJ)

Department of Pediatrics, Stanford University, Palo Alto, California.

Ananta Addala (A)

Department of Pediatrics, Stanford University, Palo Alto, California.

Hiba Abujaradeh (H)

School of Nursing, University of Pittsburgh, Pittsburgh, Pennsylvania.

Rebecca N Adams (RN)

Department of Pediatrics, Stanford University, Palo Alto, California.

Regan C Barley (RC)

Department of Pediatrics, Stanford University, Palo Alto, California.

Sarah J Hanes (SJ)

Department of Pediatrics, Stanford University, Palo Alto, California.

Esti Iturralde (E)

Department of Pediatrics, Stanford University, Palo Alto, California.

Monica S Lanning (MS)

Department of Pediatrics, Stanford University, Palo Alto, California.

Diana Naranjo (D)

Department of Pediatrics, Stanford University, Palo Alto, California.

Molly L Tanenbaum (ML)

Department of Pediatrics, Stanford University, Palo Alto, California.

Korey K Hood (KK)

Department of Pediatrics, Stanford University, Palo Alto, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH